X0306 4 2019-10-20 0 0001402328 Sunshine Biopharma, Inc SBFM 0001636418 MERZOUKI ABDERRAZZAK 731 PLACE DE L'EEAU VIVE LAVAL A8 H7Y 2E1 QUEBEC, CANADA 1 1 0 0 Chief Operating Officer Common Stock 2019-10-20 4 A 0 1100000 0.001 A 2042500 D Common Stock 2019-12-19 4 A 0 1300000 0.001 A 3342500 D Common Stock 3668 I Held by Axis Biosciences, Inc. of which Reporting Person is a control person. The amount of Securities Acquired and Securities Beneficially Owned reported herein are post the effectiveness of a February 1, 2019 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person and post the effectiveness of an April 6, 2020 reverse split of the Issuer's Common Stock wherein 1 share of Common Stock was issued for each 20 shares of Common Stock held by the Reporting Person. The Indirect Shares Beneficially Owned are reported post effective of the reverse stock splits pursuant to Footnote 1. The Indirect holdings were previously reported as 2,193 post-reverse splits shares being held by 91138107 Quebec, Inc. and 1,475 post-reverse stock splits shares being held by Axis Biosciences, Inc. whereas 91138107 Quebec, Inc. and Axis Biosciences, Inc. are one and the same entity and are reported herein as being held by Axis Biosciences, Inc. of which Reporting Person is a control person. Abderrazzak Merzouki 2020-07-13